<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39379663</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-501X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Molecular diversity</Title><ISOAbbreviation>Mol Divers</ISOAbbreviation></Journal><ArticleTitle>A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11030-024-11003-7</ELocationID><Abstract><AbstractText>The SARS-CoV-2 outbreak highlights the persistent vulnerability of humanity to epidemics and emerging microbial threats, emphasizing the lack of time to develop disease-specific treatments. Therefore, it appears beneficial to utilize existing resources and therapies. Computational drug repositioning is an effective strategy that redirects authorized drugs to new therapeutic purposes. This strategy holds significant promise for newly emerging diseases, as drug discovery is a lengthy and expensive process. Through this study, we present an ensemble method based on the convolutional neural network integrated with genetic algorithm and deep forest classifier for virus-drug association prediction (CGDVDA). We generated feature vectors by combining drug chemical structure and virus genomic sequence-based similarities, and extracted prominent deep features by applying the convolutional neural network. The convoluted features are optimized using the genetic algorithm and classified using the ensemble deep forest classifier to predict novel virus-drug associations. The proposed method predicts drugs for COVID-19 and other viral diseases in the dataset. The model could achieve ROC-AUC scores of 0.9159 on fivefold cross-validation. We compared the performance of the model with state-of-the-art approaches and classifiers. The experimental results and case studies illustrate the efficacy of CGDVDA in predicting drugs against viral infectious diseases.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aruna</LastName><ForeName>A S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0009-0000-5956-0692</Identifier><AffiliationInfo><Affiliation>Dept. of Information Technology, Government Engineering College Palakkad, APJ Abdul Kalam Technological University, Palakkad, Kerala, 678633, India. aruna.arathi@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, College of Engineering Vadakara, Kozhikode, Kerala, 673105, India. aruna.arathi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>K R Remesh</ForeName><Initials>KRR</Initials><Identifier Source="ORCID">0000-0002-2644-7244</Identifier><AffiliationInfo><Affiliation>Dept. of Information Technology, Government Engineering College Palakkad, APJ Abdul Kalam Technological University, Palakkad, Kerala, 678633, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deepthi</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6388-0103</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, Central University of Kerala (Govt. of India), Kasaragod, Kerala, 671320, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Divers</MedlineTA><NlmUniqueID>9516534</NlmUniqueID><ISSNLinking>1381-1991</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Convolutional neural network</Keyword><Keyword MajorTopicYN="N">Deep forest</Keyword><Keyword MajorTopicYN="N">Drug repurposing</Keyword><Keyword MajorTopicYN="N">Genetic algorithm</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39379663</ArticleId><ArticleId IdType="doi">10.1007/s11030-024-11003-7</ArticleId><ArticleId IdType="pii">10.1007/s11030-024-11003-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98. https://doi.org/10.1016/j.jare.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.03.005</ArticleId><ArticleId IdType="pubmed">32257431</ArticleId><ArticleId IdType="pmc">7113610</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillaiyar T, Meenakshisundaram S, Manickam M (2020) Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov Today 25(4):668–688. https://doi.org/10.1016/j.jare.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.03.005</ArticleId><ArticleId IdType="pubmed">32006468</ArticleId><ArticleId IdType="pmc">7102522</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan AA, Al-Ahmed SH, Haque S et al (2020) SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med 28(2):17CCC4-184</Citation></Reference><Reference><Citation>Ojha PK, Kar S, Krishna JG, Roy K, Leszczynski J (2021) Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to. Mol Divers 25:625–659. https://doi.org/10.1007/s11030-020-10134-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11030-020-10134-x</ArticleId><ArticleId IdType="pubmed">32880078</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, He H, Zhao L, Lv Q, Chen CY (2024) GINCM-DTA: a graph isomorphic network with protein contact map representation for potential use against Covid-19 and omicron subvariants. Expert Syst Appl 236:121274. https://doi.org/10.1016/j.eswa.2023.121274</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2023.121274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianevski A, Kushnir A, Nader K, Miihkinen M, Xhaard H, Aittokallio T, Tanoli Z (2024) RepurposeDrugs: an interactive web-portal and predictive platform for repurposing mono-and combination therapies. Brief Bioinform. https://doi.org/10.1093/bib/bbae328</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbae328</ArticleId><ArticleId IdType="pubmed">38980370</ArticleId><ArticleId IdType="pmc">11232279</ArticleId></ArticleIdList></Reference><Reference><Citation>He H, Chen G, Chen CY (2023) NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug-target binding affinity prediction. Bioinformatics 39(6):btad355. https://doi.org/10.1093/bioinformatics/btad355</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btad355</ArticleId><ArticleId IdType="pubmed">37252835</ArticleId><ArticleId IdType="pmc">10287904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooshmand SA, Zarei Ghobadi M, Hooshmand SE, Azimzadeh Jamalkandi S, Alavi SM, Masoudi-Nejad A (2021) A multimodal deep learning-based drug repurposing approach for treatment of COVID-19. Mol Divers 25:1717–1730. https://doi.org/10.1007/s11030-020-10144-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11030-020-10144-9</ArticleId><ArticleId IdType="pubmed">32997257</ArticleId></ArticleIdList></Reference><Reference><Citation>Aruna AS, Remesh Babu KR, Deepthi K (2022) A survey of recent techniques in computational drug repurposing. In: International conference on intelligent systems design and applications, Cham: Springer, pp. 565–575</Citation></Reference><Reference><Citation>Ren ZH, You ZH, Zou Q et al (2023) DeepMPF: deep learning framework for predicting drug-target interactions based on multi-modal representation with meta-path semantic analysis. J Transl Med 21(1):48. https://doi.org/10.1186/s12967-023-03876-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03876-3</ArticleId><ArticleId IdType="pubmed">36698208</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar S, Zou Q, Raza A, Alarfaj FK (2024) iAFPs-Mv-BiTCN: predicting antifungal peptides using self-attention transformer embedding and transform evolutionary based multi-view features with bidirectional temporal convolutional networks. Artif Intell Med 151:102860. https://doi.org/10.1016/j.artmed.2024.102860</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2024.102860</ArticleId><ArticleId IdType="pubmed">38552379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushpakom S, Iorio F, Eyers PA et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41–58. https://doi.org/10.1038/nrd.2018.168</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2018.168</ArticleId><ArticleId IdType="pubmed">30310233</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Jin M, Tang X, Xu J (2021) Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study. Appl Soft Comput 103:107135. https://doi.org/10.1016/j.asoc.2021.107135</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.asoc.2021.107135</ArticleId><ArticleId IdType="pubmed">33519322</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L, Shen L, Xu J et al (2021) Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures. Sci Rep 11(1):6248. https://doi.org/10.1038/s41598-021-83737-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83737-5</ArticleId><ArticleId IdType="pubmed">33737523</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongia A, Saha SK, Chouzenoux E, Majumdar A (2021) A computational approach to aid clinicians in selecting antiviral drugs for COVID-19 trials. Sci Rep 11(1):9047. https://doi.org/10.1038/s41598-021-88153-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88153-3</ArticleId><ArticleId IdType="pubmed">33907209</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L, Liu F, Huang L, Liu G, Zhou L, Peng L (2022) VDA-RWLRLS: an anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares. Comput Biol Med 140:105119. https://doi.org/10.1016/j.compbiomed.2021.105119</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105119</ArticleId><ArticleId IdType="pubmed">34902608</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xu X, Tsoka S (2022) A matrix factorization-based drug-virus link prediction method for SARS-CoV-2 drug prioritization. In: International conference on machine learning, optimization, and data science, Cham: Springer, pp. 35–47</Citation></Reference><Reference><Citation>Xu J, Meng Y, Peng L et al (2022) Computational drug repositioning using similarity constrained weight regularization matrix factorization: a case of COVID-19. J Cell Mol Med 26(13):3772–3782. https://doi.org/10.1111/jcmm.17412</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17412</ArticleId><ArticleId IdType="pubmed">35644992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F (2020) Network-based drug repurposing for novel coronavirus 209- nCoV/SARS-CoV-2. Cell Discov 6(1):14. https://doi.org/10.1038/s41421-020-0153-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0153-3</ArticleId><ArticleId IdType="pubmed">32194980</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Cai L, Meng Y, Xu J, Lu C, Yang J (2021) Indicator regularized non-negative matrix factorization method-based drug repurposing for COVID-19. Front Immunol 11:603615. https://doi.org/10.3389/fimmu.2020.603615</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.603615</ArticleId><ArticleId IdType="pubmed">33584672</ArticleId></ArticleIdList></Reference><Reference><Citation>Aruna AS, Remesh Babu KR, Deepthi K (2023) An ensemble approach for prioritizing antivirals against COVID-19 via heterogeneous network inference-based inductive matrix completion. J Comput Biophys Chem. https://doi.org/10.1142/S2737416523410041</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S2737416523410041</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu J, Song Z, Cheng X, Jiang Z, Zhou J (2023) A new integrated framework for the identification of potential virus–drug associations. Front Microbiol 14:1179414. https://doi.org/10.3389/fmicb.2023.1179414</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1179414</ArticleId><ArticleId IdType="pubmed">37675432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Zhong J, Zhu N (2023) Weighted hypergraph learning and adaptive inductive matrix completion for SARS-CoV-2 drug repositioning. Methods 219:102–110. https://doi.org/10.1016/j.ymeth.2023.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2023.10.002</ArticleId><ArticleId IdType="pubmed">37804962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalmuanawma S, Hussain J, Chhakchhuak L (2020) Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: a review. Chaos Solitons Fractals 139:110059. https://doi.org/10.1016/j.chaos.2020.110059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.110059</ArticleId><ArticleId IdType="pubmed">32834612</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepthi K, Jereesh AS, Liu Y (2021) A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing. Appl Soft Comput 113:107945. https://doi.org/10.1016/j.asoc.2021.107945</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.asoc.2021.107945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi SM, Zabihian A, Hooshmand M, Gharaghani S (2023) DRaW: prediction of COVID-19 antivirals by deep learning—an objection on using matrix factorization. BMC Bioinform 24(1):52. https://doi.org/10.1186/s12859-023-05181-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-023-05181-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, You Z, Wang L, Hu L, Wong L, Ji B, Zhao B (2021) SANE: a sequence combined attentive network embedding model for COVID-19 drug repositioning. Appl Soft Comput 111:107831. https://doi.org/10.1016/j.asoc.2021.107831</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.asoc.2021.107831</ArticleId><ArticleId IdType="pubmed">34456656</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Zhang P, Deng L (2023) DeepCoVDR: deep transfer learning with graph transformer and cross-attention for predicting COVID-19 drug response. Bioinformatics 39:i475–i483. https://doi.org/10.1093/bioinformatics/btad244</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btad244</ArticleId><ArticleId IdType="pubmed">37387168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh K, Wang Y, Chen L et al (2021) Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence. Sci Rep 11(1):23179. https://doi.org/10.1038/s41598-021-02353-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02353-5</ArticleId><ArticleId IdType="pubmed">34848761</ArticleId></ArticleIdList></Reference><Reference><Citation>Che M, Yao K, Che C, Cao Z, Kong F (2021) Knowledge-graph-based drug repositioning against COVID-19 by graph convolutional network with attention mechanism. Future Internet 13(1):13. https://doi.org/10.3390/fi13010013</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/fi13010013</ArticleId></ArticleIdList></Reference><Reference><Citation>Aruna AS, Babu KR, Deepthi K (2023) A drug-virus prediction model based on an ensemble classifier with feature optimization: a case study with COVID-19. In: International conference on communication and intelligent systems, Singapore: Springer, pp. 267–280</Citation></Reference><Reference><Citation>Das B, Kutsal M, Das R (2022) A geometric deep learning model for display and prediction of potential drug-virus interactions against SARS-CoV-2. Chemometr Intell Lab Syst 229:104640. https://doi.org/10.1016/j.chemolab.2022.104640</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemolab.2022.104640</ArticleId><ArticleId IdType="pubmed">36042844</ArticleId><ArticleId IdType="pmc">9400382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Hu X, Li G, Deng L (2023) AntiViralDL: computational antiviral drug repurposing using graph neural network and self-supervised learning. IEEE J Biomed Health Inform. https://doi.org/10.1109/JBHI.2023.3328337</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JBHI.2023.3328337</ArticleId><ArticleId IdType="pubmed">38147420</ArticleId><ArticleId IdType="pmc">10481620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Kuang L, Hu A, Zhang Q, Yang D, Wang C (2024) OGNNMDA: a computational model for microbe-drug association prediction based on ordered message-passing graph neural networks. Front Genet 15:1370013. https://doi.org/10.3389/fgene.2024.1370013</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2024.1370013</ArticleId><ArticleId IdType="pubmed">38689654</ArticleId><ArticleId IdType="pmc">11058190</ArticleId></ArticleIdList></Reference><Reference><Citation>Law V, Knox C, Djoumbou Y et al (2014) DrugBank 4.0: shedding new light on drug mefigolism. Nucleic Acids Res 42(D1):D1091–D1097. https://doi.org/10.1093/nar/gkt1068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1068</ArticleId><ArticleId IdType="pubmed">24203711</ArticleId></ArticleIdList></Reference><Reference><Citation>Öztürk H, Ozkirimli E, Özgür A (2016) A comparative study of SMILES-based compound similarity functions for drug-target interaction prediction. BMC Bioinform 17(1):1–11. https://doi.org/10.1186/s12859-016-0977-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-016-0977-x</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform 3(1):1–14. https://doi.org/10.1186/1758-2946-3-33</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2946-3-33</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajusz D, Rácz A, Héberger K (2015) Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? J Cheminform 7(1):1–13. https://doi.org/10.1186/s13321-015-0069-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-015-0069-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler DL, Chappey C, Lash AE et al (2000) Database resources of the national center for biotechnology information. Nucleic Acids Res 28(1):10–14. https://doi.org/10.1093/nar/28.1.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.10</ArticleId><ArticleId IdType="pubmed">10592169</ArticleId><ArticleId IdType="pmc">102437</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh K, Standley DM (2013) MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 30(4):772–780. https://doi.org/10.1093/molbev/mst010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mst010</ArticleId><ArticleId IdType="pubmed">23329690</ArticleId><ArticleId IdType="pmc">3603318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wang L, Qu J, Guan NN, Li JQ (2018) Predicting miRNA-disease association based on inductive matrix completion. Bioinformatics 34(24):4256–4265. https://doi.org/10.1093/bioinformatics/bty503</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty503</ArticleId><ArticleId IdType="pubmed">29939227</ArticleId></ArticleIdList></Reference><Reference><Citation>Rukh G, Akbar S, Rehman G, Alarfaj FK, Zou Q (2024) StackedEnC-AOP: prediction of antioxidant proteins using transform evolutionary and sequential features based multi-scale vector with stacked ensemble learning. BMC Bioinform 25(1):256. https://doi.org/10.1186/s12859-024-05884-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-024-05884-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar S, Raza A, Zou Q (2024) Deepstacked-AVPs: predicting antiviral peptides using tri-segment evolutionary profile and word embedding based multi-perspective features with deep stacking model. BMC Bioinform 25(1):102. https://doi.org/10.1186/s12859-024-05726-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-024-05726-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah M, Akbar S, Raza A, Zou Q (2024) DeepAVP-TPPred: identification of antiviral peptides using transformed image-based localized descriptors and binary tree growth algorithm. Bioinformatics 40(5):btae305. https://doi.org/10.1093/bioinformatics/btae305</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btae305</ArticleId><ArticleId IdType="pubmed">38710482</ArticleId></ArticleIdList></Reference><Reference><Citation>Raza A, Uddin J, Almuhaimeed A, Akbar S, Zou Q, Ahmad A (2023) AIPs-SnTCN: predicting anti-inflammatory peptides using fastText and transformer encoder-based hybrid word embedding with self-normalized temporal convolutional networks. J Chem Inf Model 63(21):6537–6554. https://doi.org/10.1021/acs.jcim.3c01563</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.3c01563</ArticleId><ArticleId IdType="pubmed">37905969</ArticleId></ArticleIdList></Reference><Reference><Citation>LeCun Y, Boser B, Denker JS, Henderson D, Howard RE, Hubbard W, Jackel LD (1989) Backpropagation applied to handwritten zip code recognition. Neural Comput 1(4):541–551. https://doi.org/10.1162/neco.1989.1.4.541</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/neco.1989.1.4.541</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, You ZH, Huang YA, Huang DS, Chan KC (2020) An efficient approach based on multi-sources information to predict circRNA-disease associations using deep convolutional neural network. Bioinformatics 36(13):4038–4046. https://doi.org/10.1093/bioinformatics/btz825</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz825</ArticleId><ArticleId IdType="pubmed">31793982</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepthi K, Jereesh AS (2021) An ensemble approach based on multi-source information to predict drug-MiRNA associations via convolutional neural networks. IEEE Access 9:38331–38341. https://doi.org/10.1109/ACCESS.2021.3063885</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2021.3063885</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Hui W, Li Q et al (2019) A learning-based framework for miRNA-disease association identification using neural networks. Bioinformatics 35(21):4364–4371. https://doi.org/10.1093/bioinformatics/btz254</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz254</ArticleId><ArticleId IdType="pubmed">30977780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciocca G, Napoletano P, Schettini R (2018) CNN-based features for retrieval and classification of food images. Comput Vis Image Underst 176:70–77. https://doi.org/10.1016/j.cviu.2018.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cviu.2018.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava N, Hinton G, Krizhevsky A, Sutskever I, Salakhutdinov R (2014) Dropout: a simple way to prevent neural networks from overfitting. J Mach Learn Res 15(1):1929–1958</Citation></Reference><Reference><Citation>Nair V, Hinton GE (2010) Rectified linear units improve restricted boltzmann machines. In: Proceedings of the 27th international conference on machine learning (ICML-10), pp 807–814</Citation></Reference><Reference><Citation>Mirjalili S (2019) Evolutionary algorithms and neural networks. Stud Comput Intell 780:43–55</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-93025-1_4</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad F, Mat Isa NA, Hussain Z, Osman MK, Sulaiman SN (2015) A GA-based feature selection and parameter optimization of an ANN in diagnosing breast cancer. Pattern Anal Appl 18:861–870. https://doi.org/10.1007/s10044-014-0375-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10044-014-0375-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerukala Sathipati S, Ho SY (2018) Identifying a miRNA signature for predicting the stage of breast cancer. Sci Rep 8(1):16138. https://doi.org/10.1038/s41598-018-34604-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34604-3</ArticleId><ArticleId IdType="pubmed">30382159</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoch S, Chauhan SS, Kumar V (2021) A review on genetic algorithm: past, present, and future. Multimed Tools Appl 80:8091–8126. https://doi.org/10.1007/s11042-020-10139-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11042-020-10139-6</ArticleId><ArticleId IdType="pubmed">33162782</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh D, Marshall S (2000) Convergence criteria for genetic algorithms. SIAM J Comput 30(1):269–282</Citation><ArticleIdList><ArticleId IdType="doi">10.1137/S009753979732565X</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou ZH, Feng J (2019) Deep forest. National Sci Rev 6(1):74–86. https://doi.org/10.1137/S009753979732565X</Citation><ArticleIdList><ArticleId IdType="doi">10.1137/S009753979732565X</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Lin H, Huang L, Peng L, Tang T, Zhao Q, Yang L (2022) Identification of miRNA-disease associations via deep forest ensemble learning based on autoencoder. Brief Bioinform 23(3):bbac104. https://doi.org/10.1093/bib/bbac104</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbac104</ArticleId><ArticleId IdType="pubmed">35325038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X, Shen L, Wang Z, Zhou L, Peng L (2021) A novel lncRNA–protein interaction prediction method based on deep forest with cascade forest structure. Sci Rep 11(1):18881. https://doi.org/10.1038/s41598-021-98277-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98277-1</ArticleId><ArticleId IdType="pubmed">34556758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X, Zhong Y, Lin W, Zou Q (2020) Predicting disease-associated circular RNAs using deep forests combined with positive-unlabeled learning methods. Brief Bioinform 21(4):1425–1436. https://doi.org/10.1093/bib/bbz080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbz080</ArticleId><ArticleId IdType="pubmed">31612203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou ZH (2012) Ensemble methods: foundations and algorithms. CRC Press, p Boca Raton</Citation><ArticleIdList><ArticleId IdType="doi">10.1201/b12207</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd K, Eng KH, Page CD (2013) Area under the precision-recall curve: point estimates and confidence intervals. In: Machine learning and knowledge discovery in databases: European Conference, ECML PKDD 2013, Prague, Czech Republic, September 23–27, 2013, Proceedings, Springer: Berlin Heidelberg, Part III 13, pp. 451–466</Citation></Reference><Reference><Citation>Mandrekar JN (2010) Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 5(9):1315–1316. https://doi.org/10.1097/JTO.0b013e3181ec173d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0b013e3181ec173d</ArticleId><ArticleId IdType="pubmed">20736804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L, Hu S, Gao J (2020) Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 14(1):58–60. https://doi.org/10.5582/ddt.2020.01012</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2020.01012</ArticleId><ArticleId IdType="pubmed">32147628</ArticleId></ArticleIdList></Reference><Reference><Citation>He H, He B, Guan L et al (2024) De novo generation of SARS-CoV-2 antibody CDRH3 with a pre-trained generative large language model. Nat Commun 15(1):6867. https://doi.org/10.1038/s41467-024-50903-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-50903-y</ArticleId><ArticleId IdType="pubmed">39127753</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili JS, Zhu H, Mak NS, Yan Y, Zhu Y (2020) Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19. J Med Virol 92(7):740–746. https://doi.org/10.1002/jmv.25798</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25798</ArticleId><ArticleId IdType="pubmed">32227493</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of Covid-19. N Engl J Med 383(19):1813–1826</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007764</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Udwadia ZF, Singh P, Barkate H et al (2021) Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis 103:62–71. https://doi.org/10.1016/j.ijid.2020.11.142</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.142</ArticleId><ArticleId IdType="pubmed">33212256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosaeed M, Alharbi A, Mahmoud E et al (2022) Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial. Clin Microbiol Infect 28(4):602–608. https://doi.org/10.1016/j.cmi.2021.12.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.12.026</ArticleId><ArticleId IdType="pubmed">35026375</ArticleId><ArticleId IdType="pmc">8747778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossignol JF (2014) Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antivir Res 110:94–103. https://doi.org/10.1016/j.antiviral.2014.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.07.014</ArticleId><ArticleId IdType="pubmed">25108173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Ruschitzka F, Patel AN (2020) Retraction-hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The lancet 395(10240):1820. https://doi.org/10.1016/S0140-6736(20)31180-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31180-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani D, Noureddine O, Issaoui N, Brandán SA (2020) Properties and reactivities of niclosamide in different media, a potential antiviral to treatment of COVID-19 by using DFT calculations and molecular docking. Biointerface Res Appl Chem 10(6):7295–7328. https://doi.org/10.33263/BRIAC106.72957328</Citation><ArticleIdList><ArticleId IdType="doi">10.33263/BRIAC106.72957328</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira M, Vale N (2022) Saquinavir: from HIV to COVID-19 and cancer treatment. Biomolecules 12(7):944. https://doi.org/10.3390/biom12070944</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12070944</ArticleId><ArticleId IdType="pubmed">35883499</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayk Bernal A, Gomes da Silva MM, Musungaie DB et al (2022) Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. New Engl J Med 386(6):509–520. https://doi.org/10.1056/nejmoa2116044</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2116044</ArticleId><ArticleId IdType="pubmed">34914868</ArticleId></ArticleIdList></Reference><Reference><Citation>Araújo R, Aranda-Martínez JD, Aranda-Abreu GE (2020) Amantadine treatment for people with COVID-19. Arch Med Res 51(7):739. https://doi.org/10.1016/j.arcmed.2020.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.06.009</ArticleId><ArticleId IdType="pubmed">32571606</ArticleId><ArticleId IdType="pmc">7290190</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakovac H (2020) COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome? Am J Physiol Heart Circ Physiol 319(4):H793–H796. https://doi.org/10.1152/ajpheart.00506.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00506.2020</ArticleId><ArticleId IdType="pubmed">32886002</ArticleId><ArticleId IdType="pmc">7516379</ArticleId></ArticleIdList></Reference><Reference><Citation>Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI (2022) The role of berberine in Covid-19: potential adjunct therapy. Inflammopharmacology 30(6):2003–2016. https://doi.org/10.1007/s10787-022-01080-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01080-1</ArticleId><ArticleId IdType="pubmed">36183284</ArticleId><ArticleId IdType="pmc">9526677</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Shukla S, Gyanchandani M (2020) Pre-trained convolutional neural networks as feature extractors for diagnosis of breast cancer using histopathology. Int J Imaging Syst Technol 30(3):577–591. https://doi.org/10.1002/ima.22399</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ima.22399</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasupa K, Sunhem W (2016) A comparison between shallow and deep architecture classifiers on small dataset. In: 2016 8th International conference on information technology and electrical engineering, IEEE, pp. 1–6</Citation></Reference><Reference><Citation>Deepthi K, Jereesh AS (2021) Inferring potential CircRNA-disease associations via deep autoencoder-based classification. Mol Diagn Ther 25:87–97. https://doi.org/10.1007/s40291-020-00499-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-020-00499-y</ArticleId><ArticleId IdType="pubmed">33156515</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>